Comparative Safety of Long-Acting Inhaled Bronchodilators

Dec-07

AUTHORS : Dr Michele Jara (Details for study: Boehringer Ingelheim Pharmaceuticals Inc), Acorda Therapeutics, Inc., 420 Saw Mill, River Road, Ardsley, NY 10502, USA – Email: mjara@acorda.com OR Dr Stephan Lanes (Details for this study: Boehringer Ingelheim Pharmaceuticals Inc), now working at HealthCore, Wilmington Office, 123 Justison Street, Suite 200, Wilmington, DE 19801, United States – Email: slanes@healthcore.com – Profile: https://www.healthcore.com/experts/stephan-lanes-phd-mph/

JOURNAL : Drug Safety

REFERENCE: 30(12):1151-1160

DOI : 10.2165/00002018-200730120-00007

Comparative Safety of Long-Acting Inhaled Bronchodilators

More publications

Comparative effect of aspirin versus clopidogrel monotherapy on incident type 2 diabetes in patients with atherosclerotic cardiovascular diseases: A target trial emulation study

Comparative effectiveness and prescribing trends of modified release versus immediate release indapamide in patients with hypertension: cohort study

Postoperative Weight Loss After Antiobesity Medications and Revision Risk After Joint Replacement